Prelude Therapeutics (PRLD) Stock Chart & Stock Price History $1.18 +0.04 (+3.07%) As of 12:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Prelude Therapeutics Stock Price Performance The Prelude Therapeutics (PRLD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 75.57%, with a year-to-date return of -7.84%. In the past month, the stock has increased 39.66%, reflecting recent market activity. As of the latest close, Prelude Therapeutics traded at $1.14 with a market cap of $64.52 million and volume of 52,158 shares. Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.89%1 Month Performance+39.66%3 Month Performance+20.12%Year-To-Date Performance-7.84%1 Year Performance-75.57% PRLD Stock Chart for Friday, September, 5, 2025 PRLD Chart by TradingView Prelude Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/04/2025$1.22$1.14-6.56%$1.21$1.1252,158 shs$64.52 million09/03/2025$1.13$1.22+7.96%$1.26$1.10256,024 shs$69.05 million09/02/2025$1.21$1.13-6.61%$1.24$1.1274,191 shs$63.96 million09/01/2025$1.21$1.21$1.30$1.17222,195 shs$68.49 million08/29/2025$1.31$1.21-7.63%$1.30$1.17222,195 shs$68.49 million08/28/2025$1.28$1.31+2.34%$1.33$1.16196,862 shs$74.15 million08/27/2025$1.22$1.28+4.92%$1.30$1.10417,229 shs$72.45 million08/26/2025$1.27$1.22-3.94%$1.30$1.13206,920 shs$69.05 million08/25/2025$1.24$1.27+2.42%$1.29$1.10634,228 shs$71.88 million08/22/2025$1.10$1.24+12.73%$1.25$1.01486,756 shs$70.18 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/21/2025$1.05$1.10+4.76%$1.21$1.03418,465 shs$62.26 million08/20/2025$0.89$1.05+17.55%$1.05$0.85370,555 shs$59.43 million08/19/2025$0.94$0.89-5.39%$0.95$0.8780,520 shs$50.56 million08/18/2025$0.87$0.94+8.52%$0.95$0.8364,639 shs$53.44 million08/15/2025$0.95$0.87-7.94%$0.93$0.8280,871 shs$49.12 million08/14/2025$0.91$0.95+4.19%$0.96$0.82221,451 shs$53.36 million08/13/2025$0.84$0.91+8.23%$0.92$0.81138,180 shs$51.21 million08/12/2025$0.83$0.84+1.33%$0.85$0.75191,674 shs$47.31 million08/11/2025$0.86$0.83-3.56%$0.89$0.8197,649 shs$46.69 million08/08/2025$0.86$0.86+0.06%$0.88$0.8360,874 shs$48.41 million08/07/2025$0.85$0.86+0.85%$0.91$0.84161,850 shs$48.39 million08/06/2025$0.84$0.85+1.01%$0.87$0.82106,882 shs$47.98 million08/05/2025$0.85$0.84-0.53%$0.89$0.8337,836 shs$47.50 million08/04/2025$0.83$0.85+2.11%$0.89$0.8269,841 shs$47.75 million Related Companies Contineum Therapeutics Stock Price Chart Vor Biopharma Stock Price Chart DBV Technologies Stock Price Chart Mereo BioPharma Group Stock Price Chart Jade Biosciences Stock Price Chart Lexeo Therapeutics Stock Price Chart Puma Biotechnology Stock Price Chart Allogene Therapeutics Stock Price Chart Tvardi Therapeutics Stock Price Chart Galectin Therapeutics Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRLD Stock Alerts